JP2015509909A5 - - Google Patents

Download PDF

Info

Publication number
JP2015509909A5
JP2015509909A5 JP2014543571A JP2014543571A JP2015509909A5 JP 2015509909 A5 JP2015509909 A5 JP 2015509909A5 JP 2014543571 A JP2014543571 A JP 2014543571A JP 2014543571 A JP2014543571 A JP 2014543571A JP 2015509909 A5 JP2015509909 A5 JP 2015509909A5
Authority
JP
Japan
Prior art keywords
composition
use according
itc
sulforaphane
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014543571A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015509909A (ja
JP6437823B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/066340 external-priority patent/WO2013078371A2/en
Publication of JP2015509909A publication Critical patent/JP2015509909A/ja
Publication of JP2015509909A5 publication Critical patent/JP2015509909A5/ja
Application granted granted Critical
Publication of JP6437823B2 publication Critical patent/JP6437823B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014543571A 2011-11-22 2012-11-21 アルコール毒性低減のための方法および組成物 Active JP6437823B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161562559P 2011-11-22 2011-11-22
US61/562,559 2011-11-22
US201161568721P 2011-12-09 2011-12-09
US61/568,721 2011-12-09
PCT/US2012/066340 WO2013078371A2 (en) 2011-11-22 2012-11-21 Methods and compositions for reducing alcohol toxicity

Publications (3)

Publication Number Publication Date
JP2015509909A JP2015509909A (ja) 2015-04-02
JP2015509909A5 true JP2015509909A5 (https=) 2015-09-03
JP6437823B2 JP6437823B2 (ja) 2018-12-12

Family

ID=48470418

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014543571A Active JP6437823B2 (ja) 2011-11-22 2012-11-21 アルコール毒性低減のための方法および組成物

Country Status (6)

Country Link
US (2) US20150087702A1 (https=)
EP (1) EP2782583B1 (https=)
JP (1) JP6437823B2 (https=)
KR (1) KR102002147B1 (https=)
CN (1) CN104520311B (https=)
WO (1) WO2013078371A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160030364A1 (en) * 2013-04-05 2016-02-04 Manuka Health New Zealand Limited Therapeutic Compositions and Uses Thereof
CN103396348B (zh) * 2013-08-21 2015-05-20 昆明龙津药业股份有限公司 蔊菜素的衍生物以及在制备抗癌药物中的应用
JP6855157B2 (ja) * 2014-10-06 2021-04-07 扶桑化学工業株式会社 水中動物用飼料、水中動物用発育向上剤、および、それらを用いた養殖魚の飼育方法
WO2016168450A1 (en) 2015-04-16 2016-10-20 The Research Foundation For The State University Of New York Acetylenic cyanoenones as therapeutics for inflammation and carcinogenesis
CN105251025B (zh) * 2015-11-11 2018-11-27 福州大学 Aldh2基因在制备预防苯乙烯致遗传毒性药物中的应用
JP2017195809A (ja) * 2016-04-27 2017-11-02 佐々木食品工業株式会社 アセトアルデヒドの代謝促進用食品組成物及びアセトアルデヒドの代謝促進剤
CN107789612A (zh) * 2016-08-31 2018-03-13 李镇坚 一种中药水果复合固体解酒糖及制备工艺
JP6867823B2 (ja) * 2017-02-13 2021-05-12 サッポロビール株式会社 アセトアルデヒドデヒドロゲナーゼ活性促進剤
US10849938B2 (en) 2017-09-13 2020-12-01 ZBiotics Company Gene expression system for probiotic microorganisms
CN107950726A (zh) * 2017-11-27 2018-04-24 广州六顺生物科技有限公司 一种具有解酒护肝作用的凝胶糖果、制备方法和应用
CN110101849B (zh) * 2019-04-12 2023-11-10 暨南大学 一种酶催化解酒作用的组合物及其制备方法与应用
CN110538173A (zh) * 2019-08-20 2019-12-06 郑州大学第一附属医院 异硫氰酸酯类化合物在制备食管癌靶向药中的应用
WO2021069615A1 (en) * 2019-10-10 2021-04-15 Zobrius Pharma As Improved anti-hangover composition, its preparation and uses
KR102460545B1 (ko) 2020-02-18 2022-10-31 주식회사 피코엔텍 신규한 돌연변이 효모를 함유하는 천식 억제용 조성물
CN111437280A (zh) * 2020-04-29 2020-07-24 重庆燕盈生物科技有限公司 一种基于雷公藤红素的新用途及其应用
CN118490676B (zh) * 2024-07-18 2024-09-13 暨南大学 杨芽黄素在制备延缓卵巢衰老和/或修复损伤卵巢和/或重建卵巢功能药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5725895B1 (en) 1995-09-15 2000-10-10 Hopkins J School Of Medicine Method of preparing food product from cruciferous seeds
KR20020014978A (ko) * 2000-08-19 2002-02-27 김기성 숙취제거 향의 조성물
US20050271754A1 (en) * 2004-06-07 2005-12-08 Cochrane Patrick W Composition for prevention or treatment of an alcohol hangover
RU2292899C2 (ru) * 2004-06-29 2007-02-10 Дмитрий Николаевич Мясников Средство и способ профилактики и уменьшения неблагоприятных проявлений острой алкогольной интоксикации (варианты) и способ получения средства
KR100661032B1 (ko) * 2005-04-19 2006-12-22 주식회사한국야쿠르트 간 기능 개선, 혈중 알코올 감소 및 항산화에 유효한조성물
CN101232822B (zh) * 2005-07-29 2012-11-14 蒂马基金会 用于减缓乙醇代谢和用于降低乙醇诱导的疾病风险的组合物
WO2007016953A1 (en) 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing alcohol induced liver cancer risk
US20080311276A1 (en) * 2007-06-12 2008-12-18 Kraft Foods Holdings, Inc. Production of Glucosinolates from Agricultural By-Products & Waste
AU2009206753B2 (en) * 2008-01-24 2014-07-03 Raptor Therapeutics Inc. Protopanaxadiol-type ginsenoside compositions and uses thereof
CN103202838A (zh) 2013-04-16 2013-07-17 缪为民 一种具有肝脏保护作用的植物提取物组合物

Similar Documents

Publication Publication Date Title
JP2015509909A5 (https=)
JP2015078230A5 (https=)
JP2014129360A5 (https=)
MX2018012686A (es) Composicion para el tratamiento de la hiperlipidemia que comprende un derivado de oxintomodulina.
JP2010174019A5 (https=)
JP2015515475A5 (https=)
WO2013066839A3 (en) Compounds and methods
WO2010010257A3 (fr) Medicaments appetissants a administration orale sous forme solide pour la prevention et/ou le traitement de l'insuffisance cardiaque chez les animaux
RU2011138101A (ru) Фармацевтическая композиция, проявляющая противовоспалительные свойства
JP2012193216A5 (https=)
ECSP11011289A (es) Formulaciones galénicas de compuestos orgánicos
RU2019110980A (ru) Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением
RU2017141536A (ru) Замещенные производные индол-5-ола и их терапевтические применения
CO7170176A2 (es) Nuevo compuesto que tiene la capacidad para inhibir la enzima deshidrogenasa11b-hidroxiesteroide tipo 1(11b-hsd1) o sal farmaceúticamente aceptable del mismo, método para producir el mismo, y composición farmaceútica que contiene el mismo como ingrediente activo
HK1201253A1 (en) Pharmaceutical compositions comprising deuterium-enriched perillyl alcohol, iso-perillyl alcohol and derivatives thereof
WO2010080754A3 (en) Nanoparticle pharmaceutical formulations
WO2012053768A3 (en) Aryloxyphenoxyacetyl-based compound having hif-1 inhibition activity, preparation method thereof and pharmaceutical composition containing the same as an active ingredient
WO2011093818A3 (en) Pharmaceutical compositions comprising salmeterol and fluticasone
MX2013012773A (es) Sustancias farmacologicas, composiciones farmaceuticas y metodos para la preparacion de las mismas.
HRP20211160T1 (hr) Kompozicije koje sadrže geraniol i suhi đumbir za uporabu u liječenju sindroma iritabilnog crijeva
ZA201404068B (en) The use of silver(i) complexes as active pharmaceutical ingredients (api's) iincluding anticancer agents
JP2017517574A5 (https=)
RU2012115543A (ru) Противоопухолевое средство
WO2015027669A3 (zh) 苯基取代化合物及其药物组合物和应用
WO2016197944A1 (zh) 无标题